Case report: application of nirmatrelvir/ritonavir to treat covid-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation

HIGHLIGHTS

• who: Jing Chen and Qing Cao and Zhiguo Tang from the University of Crete, Greece have published the research work: Case report: Application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation, in the Journal: (JOURNAL) of December/14,/2021
• what: The authors report the case of using nirmatrelvir/ritonavir (Paxlovid) to treat COVID-19 in a severe AA child after alloHSCT.

SUMMARY

Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic. The proportion of severe COVID-19 caused . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.